| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.054 | 0.3 |